Aclarion Publishes Cost-Effectiveness Analysis of Nociscan
Aclarion Inc. (Nasdaq: ACON, ACONW) has published a peer-reviewed article in Clinicoeconomics and Outcomes Research, titled “The Comparison of Cost-Effectiveness...
Biotechnology
Terumo BCT Appoints Chief Business Officer
Terumo Blood and Cell Technologies (Terumo BCT) named Patrick Daly as its chief business officer. This addition comes as the...
Aclarion Expands Nociscan Availability to Santa Monica
Aclarion Inc. (Nasdaq: ACON, ACONW) reported that its Nociscan product is now available at the Medical Imaging Center of Southern...
Aclarion Reports Stronger Positioning After Q1 Initiatives
Aclarion Inc. (Nasdaq: ACON, ACONW), the Broomfield healthcare technology company focused on chronic low back pain, announced an update on...
Aclarion Stockholders Approve Reverse Stock Split
Aclarion Inc. (NASDAQ: ACON, ACONW) announced a 1-for-27 reverse stock split of its common stock, effective before market open on...
Terumo BCT, KBIOHealth to Enhance Gene Therapy Workforce in South Korea
Terumo Blood and Cell Technologies (Terumo BCT) has signed a memorandum of understanding (MOU) with the Osong Medical Innovation Foundation...
Aclarion Expands with RadNet Affiliates in New York, New Jersey
Aclarion Inc. (Nasdaq: ACON, ACONW), the healthcare technology company based in Broomfield, plans expand Nociscan access across key markets in...
Aclarion Forms Commercial Agreement with Scripps Health
Aclarion Inc. has established a commercial agreement with Scripps Health in San Diego, Calif., expanding access to its Nociscan technology...
Terumo BCT Teams Up with National Alliance of Sickle Cell Centers
Terumo Blood and Cell Technologies (Terumo BCT) has partnered with the nonprofit National Alliance of Sickle Cell Centers (NASCC), which...
Aclarion Receives Patent for Magnetic Resonance Spectroscopy Applications
Aclarion Inc. (Nasdaq: ACON, ACONW), a Broomfield healthcare technology company, has received a Notice of Allowance from the United States...
Aclarion Announces First CLARITY Trial Site
Aclarion Inc. (Nasdaq: ACON, ACONW), a Broomfield health care technology company, has named Northwestern Medicine as the initial site for...
Aclarion Secures Funding for CLARITY Trial of Nociscan
Aclarion Inc. (Nasdaq: ACON, ACONW) has secured nearly $20 million in gross proceeds since Jan. 1, 2025, which fully funds...
